These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33102811)

  • 21. Gaps and Interventions across the Diagnostic Care Cascade of TB Patients at the Level of Patient, Community and Health System: A Qualitative Review of the Literature.
    Shah HD; Nazli Khatib M; Syed ZQ; Gaidhane AM; Yasobant S; Narkhede K; Bhavsar P; Patel J; Sinha A; Puwar T; Saha S; Saxena D
    Trop Med Infect Dis; 2022 Jul; 7(7):. PubMed ID: 35878147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.
    Sidharta SD; Yin JD; Yoong JS; Khan MS
    BMC Health Serv Res; 2018 Apr; 18(1):276. PubMed ID: 29642905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successfully Engaging Private Providers to Improve Diagnosis, Notification, and Treatment of TB and Drug-Resistant TB: The EQUIP Public-Private Model in Chennai, India.
    Ananthakrishnan R; Richardson MD; van den Hof S; Rangaswamy R; Thiagesan R; Auguesteen S; Kamp N
    Glob Health Sci Pract; 2019 Mar; 7(1):41-53. PubMed ID: 30926737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria.
    Adejumo OA; Olusola-Faleye B; Adepoju VA; Gidado M; Onoh MO; Adegboye O; Abdur-Razzaq H; Moronfolu O; Shogbamimu Y
    Trans R Soc Trop Med Hyg; 2020 Jun; 114(6):415-423. PubMed ID: 31925446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria.
    Mohammad AB; Iliyasu G; Habib AG
    Int J Mycobacteriol; 2017; 6(1):47-51. PubMed ID: 28317805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National TB program shortages as potential factor for poor-quality TB care cascade: Healthcare workers' perspective from Beira, Mozambique.
    Lisboa M; Fronteira I; Mason PH; Martins MDRO
    PLoS One; 2020; 15(2):e0228927. PubMed ID: 32059032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient and community experiences of tuberculosis diagnosis and care within a community-based intervention in Ethiopia: a qualitative study.
    Tulloch O; Theobald S; Morishita F; Datiko DG; Asnake G; Tesema T; Jamal H; Markos P; Cuevas LE; Yassin MA
    BMC Public Health; 2015 Feb; 15():187. PubMed ID: 25885789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pragmatic Management of Drug-Resistant Tuberculosis: A Qualitative Analysis of Human Resource Constraints in a Resource-Limited Country context-Ethiopia.
    Mussie KM; Gradmann C; Yimer SA; Manyazewal T
    Int J Public Health; 2021; 66():633917. PubMed ID: 34434083
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.
    Dinic L; Akande P; Idigbe EO; Ani A; Onwujekwe D; Agbaji O; Akanbi M; Nwosu R; Adeniyi B; Wahab M; Lekuk C; Kunle-Ope C; Nwokoye N; Kanki P
    J Clin Microbiol; 2012 Sep; 50(9):2905-9. PubMed ID: 22740709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of community-initiated treatment of drug-resistant tuberculosis patients in Lagos, Nigeria.
    Bakare AM; Udunze OC; Bamidele JO; Omoniyi A; Osman E; Daniel OJ
    Trans R Soc Trop Med Hyg; 2021 Sep; 115(9):1061-1065. PubMed ID: 33427297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decentralized, Community-Based Treatment for Drug-Resistant Tuberculosis: Bangladesh Program Experience.
    Daru P; Matji R; AlMossawi HJ; Chakraborty K; Kak N
    Glob Health Sci Pract; 2018 Oct; 6(3):594-602. PubMed ID: 30287534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study.
    Vanleeuw L; Atkins S; Zembe-Mkabile W; Loveday M
    BMJ Open; 2020 Feb; 10(2):e032591. PubMed ID: 32019816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.
    Sullivan K; Pease C; Zwerling A; Mallick R; Van Dyk D; Mulpuru S; Allen C; Alsdurf H; Alvarez GG
    BMC Public Health; 2021 May; 21(1):964. PubMed ID: 34020616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding Market Size and Reporting Gaps for Paediatric TB in Indonesia, Nigeria and Pakistan: Supporting Improved Treatment of Childhood TB in the Advent of New Medicines.
    Coghlan R; Gardiner E; Amanullah F; Ihekweazu C; Triasih R; Grzemska M; Sismanidis C
    PLoS One; 2015; 10(10):e0138323. PubMed ID: 26460607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
    Bajehson M; Musa BM; Gidado M; Nsa B; Sani U; Habibu AT; Aliyu I; Hussaini T; Yusuf A; Gida Y
    PLoS One; 2019; 14(11):e0225165. PubMed ID: 31743358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'We had to manage what we had on hand, in whatever way we could': adaptive responses in policy for decentralized drug-resistant tuberculosis care in South Africa.
    Kielmann K; Dickson-Hall L; Jassat W; Le Roux S; Moshabela M; Cox H; Grant AD; Loveday M; Hill J; Nicol MP; Mlisana K; Black J
    Health Policy Plan; 2021 Apr; 36(3):249-259. PubMed ID: 33582787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation of tuberculosis treatment among children in the Kampala Capital City Authority health facilities: a mixed-methods study.
    Kibirige L; Izudi J; Okoboi S
    BMC Infect Dis; 2021 Jun; 21(1):511. PubMed ID: 34074268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
    Bieh KL; Weigel R; Smith H
    BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.